financetom
Business
financetom
/
Business
/
QAD | Redzone Acquires Kavida.ai, Freeing up to 50% of Manufacturing Buyers’ Time
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QAD | Redzone Acquires Kavida.ai, Freeing up to 50% of Manufacturing Buyers’ Time
Nov 11, 2025 5:20 AM

Acquisition accelerates Champion AI roadmap, bringing agentic automation to procurement and supply-chain workflows to drive faster decisions and higher productivity.

SANTA BARBARA, Calif.--(BUSINESS WIRE)--

QAD Inc., the company transforming manufacturing and supply chains with intelligent, adaptive solutions, today announced it has reached an agreement to acquire Kavida Technologies Ltd (t/a Kavida.ai), a pioneer in agentic AI for industrial companies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111766416/en/

The move fast-tracks QAD’s Champion AI roadmap and introduces immediate, high-impact automation for manufacturers — promising to free up nearly half of a buyer’s workday by eliminating manual post-order and supplier-collaboration tasks. The closing of the transaction is subject to UK regulatory approval.

Kavida.ai’s powerful procurement agents immediately strengthen the Champion AI platform with live, high-value use cases in strategic sourcing and ERP automation, giving manufacturers faster access to measurable productivity gains.

“Manufacturers don’t have time to wait for AI to mature — they need results today,” said Sanjay Brahmawar, CEO of QAD | Redzone. “By integrating Kavida.ai’s technology and team, we’re helping our customers unlock value faster — automating critical workflows, improving supply-chain reliability, and giving every buyer, planner, and supplier a powerful digital co-pilot. This isn’t about adding another AI feature, it’s about redefining how manufacturing work gets done.”

The acquisition brings QAD | Redzone a world-class AI engineering team with deep expertise in agent safety, human-in-the-loop training, and unstructured data handling. Kavida.ai’s intellectual property around procurement agent training and inbox-to-ERP automation will serve as the foundation for new agentic use cases across QAD’s solutions.

“We built Kavida.ai to solve one of manufacturing’s most painful problems — the friction between supplier collaboration and enterprise systems,” said Anam Rahman, CEO and Co-Founder of Kavida.ai. “Joining QAD | Redzone allows us to scale that vision globally." Dr. Sumit Sinha, CTO and Co-Founder of Kavida.ai, adds: “Together we’ll accelerate the Champion AI roadmap and deliver agents that make manufacturers faster, smarter, and more adaptive.”

The Kavida.ai PO, RFQ, and Sales agents will become immediately available to QAD | Redzone customers. Kavida.ai’s founders will assume senior leadership roles within QAD | Redzone, driving the Champion AI strategy and roadmap.

About QAD | Redzone

QAD | Redzone is redefining manufacturing and supply chains through its intelligent, adaptive platform that connects people, processes, and data into a single System of Action. With three core pillars — Redzone (frontline empowerment), Adaptive Applications (the intelligent backbone), and Champion AI (Agentic AI for manufacturing) — QAD helps manufacturers operate with Champion Pace, achieving measurable productivity, resilience, and growth in just 90 days. To learn more, visit www.qad.com or call +1 805-566-6100. Find us on LinkedIn, X, Facebook and Instagram.

Source: QAD Inc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EP Wealth Advisors Expands Presence in Phoenix Region with Acquisition of Clearview Wealth Advisors
EP Wealth Advisors Expands Presence in Phoenix Region with Acquisition of Clearview Wealth Advisors
Mar 10, 2026
Clearview team sought added support and capabilities for the clients they serve across the West Coast TORRANCE, Calif.--(BUSINESS WIRE)-- EP Wealth Advisors (“EP Wealth”), a leading fee-only registered investment advisor (RIA), today announced the acquisition of Clearview Wealth Advisors, LLC (“Clearview”), a planning-focused firm serving clients across the Pacific Northwest and the Phoenix metropolitan area. Through this partnership, the...
Kunes Auto & RV Group Expands Midwest Footprint With Acquisition of Quietwoods RV and Scenic RV Locations Across Wisconsin
Kunes Auto & RV Group Expands Midwest Footprint With Acquisition of Quietwoods RV and Scenic RV Locations Across Wisconsin
Mar 10, 2026
DELAVAN, Wis., Dec. 16, 2025 /PRNewswire/ -- Kunes Auto & RV Group, one of the Midwest's fastest-growing automotive and recreational vehicle dealership groups, today announced the acquisition of Quietwoods RV and Scenic RV, including store locations in Sturgeon Bay, Fox Valley, Slinger, Wisconsin Dells and Janesville. The expansion reinforces Kunes' commitment to serving outdoor and RV enthusiasts across Wisconsin and...
Freight Technologies Announces Deal to Acquire JAK Solar
Freight Technologies Announces Deal to Acquire JAK Solar
Mar 10, 2026
HOUSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. ( FRGT ) , a logistics management innovation company offering a diverse portfolio of technology-driven solutions, announced that it has entered into a share purchase agreement to acquire JAK Solar Loans 1 Limited (“JAK Solar”). JAK Solar operates a scalable platform focused on the ownership and servicing of residential solar-related...
Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell
Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell
Mar 10, 2026
06:32 AM EST, 12/16/2025 (MT Newswires) -- Organogenesis ( ORGO ) said late Monday that it plans to file a Biologics Licenses Application for ReNu, its amniotic suspension allograft developed to manage symptomatic knee osteoarthritis, by the end of the year. The company said the move followed the successful completion of a planned Type-B meeting with the US Food and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved